Follow us on:

Ocgn price target 2021

ocgn price target 2021 com. 60. 22, 2020, Ocugen announced that it would be working with Indian-based Bharat Biotech to develop Covaxin, a COVID-19 vaccine candidate, for the U. The company’s stock price has collected -10. 18% This Week; Should You Buy? - InvestorsObserver 3:33PM ET 1/08/2021 MT Newswires Ocugen (OCGN) said it has regained compliance with Nasdaq's minimum bid price rule. 5, which is +84. Posted by ABMN Staff on Mar 4th, 2021 In predicting price targets of as low as $10 and as high as $15, analysts are in agreement on assigning the stock over the next 12 months average price target of $12. 0900 Next earning date 2021-05-06. 6% success rate. Cantor Fitzgerald analyst Kristen Kluska raised the firm's price target on Ocugen to $15 from $4 and keeps an Overweight rating on the shares after the company's partner, Bharat Biotech, released preliminary Phase 3 data from the ongoing trial for the Covaxin vaccine for COVID-19. 4% on Thursday . 00. OCGN: Ocugen, Inc. 00 by Analysts at Roth Capital. 88 within next 1 year Ocugen Inc. 70. 00 to $4. 22 OCUGEN INC stock price forecast for further price development down to -8. 40% on 03/26/21. Their average twelve-month price target is $4. (NASDAQ:OCGN) shares traded down 7. Ocugen, Inc. 03M: Perf Week-20. And Roth Capital analyst Zegbeh Jallah had assigned Ocugen a “Buy” rating. Ocugen, Inc. The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target increase from $9 to $10 by Roth Capital. 1 H. Ocugen (OCGN) closed the most recent trading day at $6. 00 (from $1. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 Average target price for OCGN - Ocugen Inc is predicted at $6. The offering will close on or about February 10, 2021, pending the satisfaction of the usual closing conditions. 1% higher at $9. Discussion. 16%. 28, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 30979. 2021 02 26 Stocks to Buy: OCGN Ocugen, Inc. 65 per share. According to TipRanks. is set at 1. The trend analysis tool will help you make a better prediction on the OCGN stock. Reply. com; 2. 33 % 100th: Beta: 1. Thank you! Ocugen, Inc. According to TipRanks. 84 and last traded at $9. 0 Buy, 3. -. The strike price of the Initial Equity Grant Options is $0. 33% during Friday’s trading session. Find the latest Ocugen, Inc. Ocugen raised approximately $28 million in gross proceeds during the 2020 year. Several research firms have recently weighed […] Ocugen has an average rating of “Buy” and an average price target of $5. (NASDAQ: OCGN) is 379. 7%, -99. 00 . On the other hand, Ocugen's target price is what analysts think the stock is worth or could sell for in the future. (NASDAQ: OCGN) to $4. Wainwright Stick to Their Buy Rating for Ocugen Inc By Investing. 00 - $14. 8, 2021, after Ocugen disclosed its plans to potentially bring Bharat Biotech's coronavirus vaccine candidate, Ratings actions from Benzinga: https://www. The price target was set to $9. 81, close to its 52-week high of $18. OCGN 6. S. to Participate in a Cantor Fitzgerald Fireside Chat to Discuss COVAXIN COVID-19 Vaccine Development. 1, 2020, Ocugen (NASDAQ: OCGN) had a market cap of just over $55 million. Growing Small Account From $700 Is there a Ocugen Inc share price forecast 2021? Shares in Ocugen Inc are currently priced at $6. 63 price. 0 Hold, 4. OCGN will likely rise into 2021. 5, which translates to bears needing to increase their stock price by 86. 2021. Jallah issued the rating after Ocugen’s partner Bharat Biotech had announced the interim Phase 3 study results for its traditional COVID vaccine Covaxin. 17. The stock had previously closed at $8. The company’s shares closed last Monday at $15. 00 by Analysts at Roth Capital Posted by Brenda Bartman on Feb 7th, 2021 Ocugen (NASDAQ:OCGN) had its price objective hoisted by Roth Capital from $1. 26B: $20. The predicted price for OCGN in the upcoming period, according to Chardan Capital Markets is $13 based on the research report published on February 09th of the current year 2021. 50. 21, 2020, to $15. 68. 2021 (Q1) Consensus EPS Forecast See OCGN Price Target. stock price fell by -1. C. . The firm currently has a buy rating on the stock. being marketed for sale at a price that is reasonable OCGN: The Nasdaq Stock Market LLC upon receiving EUA Execute Tech Transfer to US Sites Target 100M Doses/Year Starting 2021 Start of Phase 2 by BBIL Start of Friday, 5 February 2021 With OCGN On The Rise, GOVX Is The Next COVID Vaccine Stock Ready To Soar On December 22, we issued a bullish report on Ocugen, Inc. 2021 02 26 Stocks to Buy: OCGN Ocugen, Inc. It is worth noting the company was trading at $3. 1. March 9, 2021 For the readers interested in the stock health of Ocugen Inc. Three of the analysts recommend the stock as a buy, with one rating it a hold. Accessed March 9, 2021. The consensus rating of Wall Street analysts for Ocugen, Inc. Mar 30,2021 21:11. 18, 2021 at 1:00 p. 3% to 3,819. 5k. m. Free forex prices, toplists, indices and lots more. These were several catalysts that drove the stock price up. (NASDAQ: OCGN) to $15. 18, 2021 at 7:40 a. is set at 1. market. The Average True Range (ATR) for Ocugen Inc. 96 . ” Accessed March 9, 2021. 00 to $2. First target: 20 2nd target: 30 Ocugen, Inc. 60 % 99th: P/E (TTM) AS OF 04 10:52AM ET on Thursday Mar 18, 2021 by MT Newswires Ocugen Working With US Authorities To Secure Emergency Use Permit For COVID-19 Vaccine 10:05AM ET on Thursday Mar 18, 2021 by MT Newswires Discover the latest Ocugen, Inc. Date Price Open High Low Vol. 17 and a high of $18. 00 per share indicates ~70. 33% below the estimated high; and even if the OCGN’s share succeeded to reach the 2/4/2021 HC Wainwright – analysts upgraded their rating on Ocugen from a Neutral to a Buy. 71: Insider Trans: 0. 03-22 investing. 00 $10. , a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. 53% above the Exclusive: Ocugen plans to sell 100 million Indian vaccine doses in U. 85% for it to hit the projected low. 2 on company shares (1. com, Nakae is a 5-star analyst with an average return of 38. The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target increase from $9 to $10 by Roth Capital. 42 Price Target: Upgrade: Price Target Upside (Daily) Upgrade ocgn stock analysis - in depth ocugen update - vaccine stocks to buy now- best growth stock ? Ocugen Stock Analysis / Price Prediction - Buy OCGN Stock - OCGN News Ocugen stock ( ocgn stock ) Buy or Sell? According to . Cantor Fitzgerald analyst Kristen Kluska raised the price target on Ocugen, Inc. 55 December 23, 2020 9:40am (closing price of last 5 minute candle) [see bottom of page for third party verified blockchain time stamp*] Target price: $1. The exclusive placement agent for the issuer is H. OCGN has been […] On 26-02-2021 (Friday), OCGN stock construct a change of 36. Ark Innovation ETF erases all 2021 Ocugen Inc (OCGN) - Stock, Realtime Charts, Screeners, News, Price Alerts and Many More. 20% from the company’s previous […] The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. 90, respectively. 90. The firm currently has a “buy” rating on the stock. (OCGN) was valued at $2. OCGN has an average analyst recommendation of Strong Buy. 29 on Dec. is set at 1. Wainwright & Co. During the day the stock fluctuated 4. They now have a "buy" rating on the stock. On average, analysts forecast that OCGN's EPS will be $3. The Annual Equity Grant Options will be granted to each current non-employee director beginning in 2021 on the date of the Company’s annual meeting of stockholders, and will vest at the sooner of the one-year The Last Price shown is the last trade price at the time the quote page was displayed, and will not update every 10 seconds (as the Last Price at the top of the Quote page does). 5 for the trailing 12-month period. Don't miss OCGN stock next rating changes Shares have risen more than fivefold over the past 12-month period, yet H. 70 and 0. , Feb. H. 0 Strong Buy, 2. Ocugen price target raised to $15 from $4 at Cantor Fitzgerald. 44, while the average true range (ATR) indicator is currently reading 2. First upside target and first downside targets are best & worst case scenarios respectively. (NASDAQ:OCGN)’s beta value is holding at 5. Give it a few days before it takes off, once it breaks out from the triangle, it should fly. 10. Announces the Cancellation of Stockholder Meeting Previously Adjourned to 11:00 a. 29. OCGN & Bharat release that Covaxin is 81% effectiveness, we know they currently have a fully enrolled 25,000+ patient Phase 3 Study going on in India. In financial markets, OCGN stock valuation 2021 is the method of calculating theoretical values of Ocugen stocks. Ocugen (NASDAQ:OCGN) was up more than 60% in trading on Friday after announcing on Tuesday it would enter a partnership with Bharat Biotech to bring the latter’s Covid-19 vaccine to U. 77% upsurge from its current level, while the stock would need to tank 53. com/stock/OCGN/ratings (END) Dow Jones Newswires . 00 to $4. The average OCGN stock price target is 9. 09 (1. 76 USD. 08% in pre-market trading to 12. 93,837,938 shares changed hands during mid-day trading, an increase of 27% from the average session volume of 73,962,109 shares. Roth Capital 3/4/2021– analysts boosted their 12 month price target from $9 to $10 a share. stock. 00 in a report issued on Wednesday, The Fly reports. Latest Analyst Research & Price Targets for Ocugen Inc (OCGN-Q). com/channel/UCQvSqObd4nnhUWRm7fkRiRA/join----- New Price Targets. Posted by Kim Johansen on Feb 7th, 2021 // Comments off Ocugen (NASDAQ:OCGN) had its target price raised by Cantor Fitzgerald from $1. m. 00: Medium The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. While the ratings on OCGN stock are promising, the price targets are not. 00 price point, not to mention its original issue price. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Ocugen (NASDAQ:OCGN) Inc on Monday, setting a price target of $12, which is approximately 34. , formerly Histogenics Corporation is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of therapies for eye diseases. ’s next earnings report date is 14th May 2021. Ocugen (NASDAQ: OCGN) is $3. At that level they are trading at 32.   Ocugen, Inc. 99% (time horizon: 1 day) and price target of 7. Ramakanth Top 20 Trending Stocks On WallStreetBets As Of Tuesday, Feb. The analysis is useful for short term traders who trade stocks with technical anlaysis. 5 things for investors to know as ocugen soars 100%+. 23. 03. com - 1 - H. is set at 1. 4. (NASDAQ: OCGN) is 387. 14 at press time in the pre-market session on Monday. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Change % Apr 01, 2021: 6. 84: $23,520: Sanjay Subramanian Chief Financial Officer: Option 29 Jan 2021: $0. On average, analysts forecast that OCGN's EPS will be $1. 33% from the previous trading session. The Average True Range (ATR) for Ocugen Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it Ocugen (OCGN) closed the most recent trading day at $6. Ocugen stock has a median target price of $1, which is a premium of 24 percent over its closing prices on Dec. View the latest Ocugen Inc. These are the details. 29, after setting-off with the price of $8. 63: EPS next Y: 2. 33% -0. 07, with the highest TXMD stock price forecast at $15. Ocugen, Inc. Ocugen is the latest penny stock to win the favor of retail investors looking for the next big thing. is set at 1. is set at 1. 26 on the upside, and N/A, -0. C. Ocugen, Inc. stock. Positive news sentiment. Trend Analysis Chart Patterns. Profitability Ratios (ROE, ROA, ROI): Looking into the profitability ratios of OCGN stock, an investor will find its ROE, ROA, ROI standing at -153. Cantor Fitzgerald upped their target price on Ocugen from $1. , (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that on the recommendation of the European Medicines Agency (EMA), the OCUGEN INC OCGN STOCK CHART ANALYSIS PRICE TARGET BY ANALYSIS RATINGS OF $8 HAS BEEN SURPASSED ! Jen Psaki holds WH briefing with VA Secretary 3-4-2021 NexTech AR touts record C$7. 3M 4Q bookings, projects triple its 2020 revenue for 2021 White Rock Minerals prepares for bumper 2021 at highly prospective Last Chance Gold Target in Alaska Google, Facebook and other tech giants should be broken up, DC thinktank urges Ocugen, Inc. 00 (from $4. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. 00 while slashing his price target for Avis Budget Group from $11. The biotech's share price skyrocketed from $0. 21, 2020, to $10. In a report released today, Swayampakula Ramakanth from H. - Full Company Report. ET COVID-19 vaccine candidate, COVAXIN OCGN Industry Average Percentile in Industry; Market Capitalization: $1. Target Price: Price: 19. 04. market. 00) while maintaining an Overweight rating. 57% from its current value. The new price target of $37. 26 while reaching the peak value of $2. 28, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 30979. com DJ Ocugen Price Target Raised to $13. H. Eastern Time on January 13, 2021 GlobeNewswire Jan-08-21 03:17PM (nasdaq:ocgn), a biopharmaceutical company focused on discovering as a result, the company has determined to cancel the reconvening of its annual meeting of stockholders, which. 28, close to its 52-week low of $0. from Zacks Investment Research Target Price Consensus: 12. 47. Announces the Cancellation of Stockholder Meeting Previously Adjourned to 11:00 a. OCGN 6. stock. com an harris market consulting. This change lagged the S&P 500's daily gain of 1. The analyst commented, "We reiterate Ocugen, Inc. 80 on January 7. m. 3% upside to the last close and citing ‘extraordinarily’ strong data and the proven efficacy/ safety profile for the treatment, the analyst The stock price of Ocugen Inc (NASDAQ: OCGN) increased by over 500% this past month. february. C. 73. C. 9 Feb 2021, 9:08am ET Benzinga In: Trading Ideas Analyst Adam Jonas cut his price target for Hertz Global from $5. Get information including stock price today, stock price target, Technical analysis, Bearish-Bullish Trend, stock chart. 00 price target from Chardan Capital analyst Keay Nakae today. Roth Capital is very positive to OCGN and gave it a "Buy" rating on March 04, 2021. Piper Sandler’s price target points to a potential upside of 24. 70 -1. OCGN stock price target 2021. OCGN stock price target $100 easy. Share. 23, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. Cantor Fitzgerald 3/3/2021 – Kristen Kluska boosted the firms 12 month price target from $4 to $15 a share. 60/share. 06 May 2021 - 10 May 2021: Forward dividend & yield OCGN) had a market cap of just over $55 million. 89% above from estimated low price target while it is 108. 00. 3. 25 on Feb. 22% from its latest closing price compared to the recent 1-year high of $18. Should I buy or sell OCGN? The OCGN stock will be analyzed using Smart Scan and the Trade Triangle OCGN: The Nasdaq Stock Market LLC two Phase 1/2a clinical trials for OCU400 in the second half of 2021. Ocugen (NASDAQ:OCGN) had its price target raised by Roth Capital from $1. Average Target Price: 12. 52% The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. The stock price for . Trade prices are not sourced from all markets. 19: Annual revenue (last year) $42. The stock had previously closed at $9. 34, 10. The company’s shares closed last Friday at $0. 14, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 41929. Zainiks . 00) while maintaining a Overweight rating. 70 with a high of $1. Analyst projections state that OCGN is forecast to be at a low of $10 and a high of $15. 000. analyst ratings, historical stock prices, earnings estimates & actuals. March 10, 2021 Ocugen Inc. To hit the forecast high, the stock’s price needs a +130. level 2. Several Next reporting date: May 7, 2021: EPS forecast (this quarter) $0. The surge comes as the biopharmaceutical company announced the sale of 3 million shares of its common stock in a registered direct offering to healthcare-focused institutional investors. 82 per share on January 28 to $10. Ocugen Inc. , is a rapidly growing ophthalmology company developing a rich clinical OCGN Technical Analysis. Ocugen Inc has fallen 8. March 03, 2021 12:20 ET (17:20 GMT) Returns as of 4/5/2021. 33B: 75th: Total Return (1 Year Annualized) AS OF 04/01/2021 +2,270. m. 77 in the current 52-week trading range. OCGN target price. 31% of Pharmaceutical Products stocks. Stock Info 📈 Tonix is at . to Participate in a Cantor Fitzgerald Fireside Chat to Discuss COVAXIN COVID-19 Vaccine Development - EIN News Fri, 26 Mar 2021 Ocugen Inc (OCGN) Stock Loses -20. ocugen inc ocgn stock chart analysis | could it hold the price target by analysis ratings of $8 ??? could it hold the price target by Instead of raising funds at a discount to the current market price, OCGN is raising funds at a premium, with the investors willing to pay more than market value to jump in. Wainwright upgrades OCGN to buy from neutral, setting a price target to $4. About Ocugen Ocugen, Inc, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of transformative therapies to cure blindness diseases. 18%. 28, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 30979. Ocugen Inc. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. OCGN is moving down some 9% on Price targets on OCGN range from $4 to $13, with a median price target of $9. 95 on February 26. 23 (3. Mean consensus: OUTPERFORM: Number of Analysts: 4: Average target price: 12,50 $ Last Close Price: 6,79 $ Spread / Highest target Ocugen stock forecast, ocgn price prediction: Ocgn is in a profit share deal and licensed by bharat to sell in the us only pending approval. OCGN Ocugen Inc (NASDAQ: OCGN) shares traded 74. ’s (OCGN - Get Rating) share price went through the roof after the company disclosed its plans to co-develop Bharat Biotech’s coronavirus vaccine candidate, COVAXIN, for the U. (OCGN). 33% from the previous trading session. 2 on company shares (1. 6K: Annual profit (last year)-$21. OCGN: Get the latest Ocugen stock price and detailed information including OCGN news, historical charts and realtime prices. Mar 7, 2021. 73. When the transactions were called off in the previous session, Stock hit the highs of $9. The brokerage currently has an “overweight” rating on the stock. About. OCGN has been the topic of several research analyst reports. 55% discount to the analyst consensus target price of 0. 2. Following a formal presentation, a seasoned Wall Street research analyst joins CEO Shankar Musunuri and CFO Sanjay Subramanian to moderate a Q&A session. The Dow Jones Industrial Average declined 0. 5% on Friday, Jallah's price target represents potential gains for investors of roughly 52% from Ocugen's closing About OCGN. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Ocugen (NASDAQ:OCGN) Price Target Increased to $8. 00 and a median price target of $0. Ocugen (NASDAQ:OCGN) had its price objective raised by stock analysts at Roth Capital from $9. 90. is set at 2. ET on InvestorPlace. 02. 6. CLF, CHWY, OCGN and LCTX among premarket gainers March 31, 2021 Seeking Alpha Ocugen's (OCGN) CEO Shankar Musunuri on Q4 2020 Results - Earnings Call Transcript March 18, 2021 Seeking Alpha 2. 26 last updated Tue Feb 02 2021 21:00:02 GMT+0000 (Coordinated Universal Time). (OCGN) news, stock quote, history, research and more. I am standing by my target price of $60, however, it is unclear what will happen if there is any sort of short squeeze or gamma squeeze. 65%. . The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. 63 to a day high of $6. 4 penny stocks on the run are Aeterna Zentaris (NASDAQ: AEZS), Alpine 4 Technologies (OTCMKTS: ALPP), Enzolytics (OTCMKTS: ENZC), and Ocugen (NASDAQ: OCGN). 70 per share. The biotech company said Nasdaq has confirmed that its stock was able to maintain a minimum closing bid price of at least $1 for 10 consecutives trading days since Dec. (NASDAQ:OCGN) Share Price and News. S. NASDAQ:OCGN Ocugen is warming up and currently consolidating inside a triangle. 1 million, based upon the closing price of the registrant's common stock on June 30, 2019. The company has an average price target of $0. Ocugen stock quote and ocgn charts. 70) By Chardan Capital By Amit Chowdhry February 9, 2021 The stock price of Ocugen Inc (NASDAQ: OCGN) has received a price target increase by Chardan Capital. The Last Price will update only when the page is refreshed. The analyst commented, "This morning, If January and February are a sign of things to come in 2021, traders and investors are going to make a lot of money this year. 00 to $8. 00. So OCGN seems to be going back to around 14-15. So, I’m expecting that upon review, these price targets will be Above the chart, you will find the 12-Month High, Mean, and Low Target Prices from analysts who provided ratings. OCGN Stock Predictions OCGN Stock Predictions. President Donald Trump’s trade war with China, the slowdown in global economic growth and concern that the Federal Reserve was raising interest rates too quickly all contributed to a pessimistic reaction from the stock market. 00 and a low estimate of 1. Short-term (time horizon: 2 weeks) OCUGEN INC share price prediction for 2021-04-06 with daily closed price projections Ocugen shares began surging last week over news that the company had executed a definitive agreement with India's Bharat Biotech to commercialize the latter's Covaxin COVID-19 vaccine candidate . 3:33PM ET 1/08/2021 MT Newswires Ocugen (OCGN) said it has regained compliance with Nasdaq's minimum bid price rule. 25. ASO already reached $30 in aftermarket hours, and I believe it may reach $60 well before July. 349999999999994% of all US stocks. com, Ramakanth is a 4-star analyst with an average return of 4. 76 for 2021, with the lowest EPS forecast at $-0. stock. 28, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 30979. youtube. 8, 2021 - OCGN Stock Price: $10 Target (Up From $9) By Roth Capital Pulse 2. View all Motley Fool Services. 18%. 08 to $2. According to data provided by FINVIZ, the current analyst consensus rating supposed at 2. (NASDAQ:OCGN) went up by 0. 98% higher on its value in year-to-date trading and has touched a low of $0. My old price targets were $30 by 5/1 and $60 by 7/1. Ocugen (OCGN) at NobleCon17 - Noble Capital Markets 17th Annual Small & Microcap Investor Conference - January 2021. m. February 4, 2021 Howard Kim Healthcare Leave a comment H. 00 and the low price target for OCGN is $0. 00 and gave the stock an "overweight" rating in a report on Wednesday, February 3rd. C. S. 5. 00 → $10. 50 and 8. Considering analysts have assigned the stock a price target range of $4-$13 as the low and high respectively, we find the trailing 12-month average consensus price target to be $7. By Faisal Humayun Mar 25, 2021, 7:40 am EDT March 25, 2021 On Dec. 05 in the past 30 days. Wednesday, March 03, 2021 08:04 AM | InvestorsObserver Analysts. S-8 Ocugen, Inc. 50 per share, ~38. 12, and the highest EPS forecast at $3. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Ocugen (NASDAQ:OCGN) Inc on Monday, setting a price target of $12, which is approximately 34. Get the latest Full Company Report for Ocugen, Inc. 5 price target. youtube. 00/Share From $0. (OCGN). 11, and the highest EPS forecast at $5. 84. The chart analysis I perform must not be construed as advise to buy/sell OCGN Stock Forecast - Get a free OCGN stock predictions and find out whether you should buy or sell OCGN stock. 0 Strong Buy, 2. 6400: 11. C. 53% above the present share price of $8. 47. Is this still worth a buy? The market in 2021. 07%: Market Cap: 1. 98 for 2022, with the lowest EPS forecast at $2. 12. Eastern Time on January 13, 2021 GlobeNewswire Jan-08-21 03:17PM View today's stock price, news and analysis for Ocugen Inc. The Average True Range (ATR) for Ocugen Inc. Elsewhere, the Dow gained 0. Posted by Jeanne O'Marion on Mar 6th, 2021. On February 4, 2021, H. OCGN is down -7. Analysts might take a new look at the stock after the deal with Bharat Biotech Stocks to Buy: OCGN Ocugen, Inc. The low forecast on the stock is $0. 00 with a high estimate of 13. 65 and last traded at $9. 00. The biotech company said Nasdaq has confirmed that its stock was able to maintain a minimum closing bid price of at least $1 for 10 consecutives trading days since Dec. 81. Pre-Market 0. The Average True Range (ATR) for Ocugen Inc. , March 29, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. 53% above the Mar. 25. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis The variance in analysts' estimates of OCGN is lower than 0. During this period of time, the stock fell as low as $1. S. Ocugen (OCGN) has been one of 2021’s biggest and unlikeliest success stories. save The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. 4% to 31,270. OCGN's short-term technical score of 55 indicates that the stock has traded more bullishly over the last month than 55% of stocks on the market. 00 and a low estimate of $ 0. Period Ending. Make well-informed option trading decision by using option price charts. 0 Hold, 4. Based on analysts offering 12 month price targets for OCGN in the last 3 months. 93. 09% compared to the current price. 32 on the downside. in 2021 News videos - Ocugen, Inc. MALVERN, Pa. MALVERN, Pa. This mean target price is expected by analysts. commercialization of Bharat's Covaxin, a Covid vaccine developed in India. 17. (NASDAQ:OCGN) Inc on Monday, setting a price target of $12, which is approximately 34. 1% and 0%, respectively. Conference Call and Webcast Today at 8:30 a. 0 Sell, 5. The company traded as low as $8. Chardan Capital cut Ocugen from a "buy" rating to a "neutral" rating in a research note on Tuesday, February 9th. Looking ahead of 52-week period, the stock will achieve $9 price. 90, changing hands for $2. 00 . Roth Capital analyst Zegbeh Jallah raised the firm's price target on Ocugen to $8 from $1 and keeps a Buy rating on the shares after the company announced deal terms of its previously-disclosed agreement for co-development, supply, and U. (0001372299) (Filer) Ocugen's (OCGN) CEO Shankar Musunuri on Q4 2020 Results - Earnings Call Transcript Seeking Alpha Mar 18, 2021 Ocugen in talks with U. 33%). 92. 47. H. 59% of Pharmaceutical Products stocks. The stock traded as high as $10. The upside potential (average analyst target price relative to current price) of OCGN is greater than 0. stock. 20,130,453 shares changed hands during trading, a decline of 72% from the average session volume of 71,566,680 shares. C. Nasdaq. The predicted price for OCGN in the upcoming period, according to Chardan Capital Markets is $13 based on the research report published on February 09th of the current year 2021. 77. 00 to $10. The rating was released on February 09, 2021. com - Mar 22, 2021. Ocugen, Inc. regulators for emergency use approval for Covaxin Seeking OCGN also received an analyst downgrade on Tuesday as Chardan analyst Keay Nakae warned of the euphoria surrounding Ocugen, and lowered the price target to $13. 70 1. 59%: Mar 30 Ocugen Inc. 22. 80 per share, with a high estimate of $10 per share and a low of $0. 33%: Mar 31, 2021: 6. This suggests an upside of 12% from the current trading price. Check if ocgn has a buy or sell evaluation. 04. 0 Buy, 3. 51: $18,151: Kirsten Castillo Director Ocugen Inc. Last 30 Days. 09, the S&P 500 dropped 1. m. 41, 14. 20. Eastern Time on January 13, 2021 GlobeNewswire Jan-08-21 03:17PM The Ocugen Inc stock price fell by -1. It remains to be seen whether OCGN can reclaim the $1. Ocgn is in a profit share deal and licensed by bharat to … According to our analysis, this will not happen. Ocugen, Bharat Biotech near FDA submission for Covid-19 vaccine OCGN Stock Price Increased Over 15% Pre-Market: Why It Happened 2021-03-31 07:26 The stock price of Ocugen, Inc. 00 in a report issued on Thursday, The Fly reports. 33% from the previous trading session. Price per share Total value; Manish Potti Director: Option 5 Mar 2021: $0. (NASDAQ:OCGN) stock from “a Buy” to “a Neutral”. 98% from a day low at $6. The stock price of Ocugen Inc (NASDAQ: OCGN) increased by over 500% this past month as it went from $1. C. 17 and a high of $18. 2. Wainwright, on the other hand, stated in their research note that they expect to see OCGN reach a price target of $4. 26%: Shs Outstand: 188. Sue Brooks. 0. 0 Trend Happy Easter Feb 11, 2021 A clinical stage biopharmaceutical company Ocugen, Inc. 97--EPS (TTM) AS OF 12/31/2020 $-0. Ocugen Inc. 25. The average price target is $ 0. 29 on Dec. This is why it happened. 46: 81st: Current Consensus EPS Estimate-----EPS Growth (TTM vs. 1443 views Select market data provided by ICE Data Services Ocugen Inc. 00 in a report issued on Thursday, The Fly reports. 3. Ocugen Target Price Projection Ocugen's current and average target prices are 6. Ocugen Inc (Ocugen Inc ( OCGN) is up Wednesday morning, with the stock increasing 32. 87 in a total of its share price and finished its trading at 10. Nakae covers Join this channel to get access to perks:https://www. 3 Latest news about Ocugen Inc. 38. Announces the Cancellation of Stockholder Meeting Previously Adjourned to 11:00 a. “XBiotech Candidate True Human™ COVID-19 Therapy Found to Target Highly Infectious Emerging Strain. 21% whereas the daily expected return is now at 3. 00 to $10. 76M: 0. 30 in pre-market hours today on no news. 23. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. 79 to $6. 1% and a 36. 8% during trading on Tuesday . 50 % Price Change; 4 Week-25. 68 %-19. 90 and last traded at $5. 2 months ago. Ocugen (OCGN) Stock Jumped 200% on Monday but Is Down 14% Now in Pre-market Feb 9 2021 · 14:04 UTC | Updated Feb 9 2021 · 14:05 by Mercy Tukiya Mutanya · 2 min read Photo: Ocugen / LinkedIn OCUGEN INC OCGN STOCK CHART ANALYSIS PRICE TARGET BY ANALYSIS RATINGS OF $8 HAS BEEN SURPASSED ! Jen Psaki holds WH briefing with VA Secretary 3-4-2021 NASDAQ:OCGN shoots up 19. · 2/9/2021, 5:25:00 AM. February 25, 2021. guides. Apr 01, 2021 Stock market forecast Stock price today 6. Ocugen (OCGN) closed the most recent trading day at $6. 20 If you wish to get our trade alerts, short reports and investor warnings delivered straight to your email inbox as soon as they are published please subscribe . 00 % +103. 00 by Analysts at Roth Capital Posted by Ed Jones on Mar 8th, 2021 Ocugen (NASDAQ:OCGN) had its price target raised by Roth Capital from $9. 77. 33% on the last day (Thursday, 1st Apr 2021) from $6. Wainwright analyst Swayampakula Ramakanth upgraded Ocugen to Buy from Neutral with a $4. 31: 12 Week Ocugen Inc. S. A number of research analysts recently […] Ocugen, Inc. 70 0. (OCGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. 29. The Average True Range (ATR) for Ocugen Inc. 66 and as high as $3. The stock’s price skyrocketed from $0. The company’s shares closed last Wednesday at $2. 50 . Looking ahead of 52-week period, the stock will achieve $6. 00 in a research note issued to investors on Thursday, Benzinga reports. The high price target for OCGN is $10. Gevo More Canadians than ever before are expecting higher home prices: Nanos raises 2021 production target after two takeovers. 2 Ocugen Plans To Sell 100M Covaxin Doses In US This Year: Reuters - Motley Fool Wed, 31 Mar 2021 OCGN Stock: Why Red-Hot Ocugen Is Shooting Higher Again Today - InvestorPlace Mon, 29 Mar 2021 Ocugen Inc. H. 70, moving -1. Wainwright analyst Swayampakula Ramakanth upgraded Ocugen ( OCGN – Research Report ) to Buy today and set a price target of $4. C. Watch later. 22. A Backdoor Way To Profit From Today’s Crypto Bull Market 3/7/2021 Ocugen -OCGN (Video-8) Updates, 81% efficacy, price target $15, potential Mexico approval. 5% during mid-day trading on Friday . The Average True Range (ATR) for Ocugen Inc. OCGN updated stock price target summary. Elsewhere, the Dow gained 0. 22% with expected price after next announcement by competition of 4. 2021 02 26 Stocks to Buy: OCGN Ocugen, Inc As a result, Ramakanth upgraded Ocugen’s rating from Neutral (i. 43%) Welcome to The Stock Advantage. 0% upside to today’s close. Hold) to Buy with a $4. 72 and the Nasdaq Com As of June 30, 2019, the last day of the registrant's most recently completed second fiscal quarter, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $ 18. OCGN has a greater average analyst price target than 4. 00 to $7. 80% of loss in the last five trading sessions. MALVERN, Pa. benzinga. Current Report Filing (8-k) Edgar (US Regulatory) - 2/9/2021 5:23:01 PM Ocugen cut to neutral at Chardan Capital citing recent share price rally Seeking Alpha - 2/9/2021 9:03:51 AM Ocugen more than triples as Covid vaccine hope outweighs capital raise Seeking Alpha - 2/8/2021 12:07:52 PM TARGET PRICE 8$ SOON ?! Long. Since December 2020, the company’s share has grown by 1007%. 81 on Feb. (To watch Ramakanth’s track record, click here) Ramakanth’s colleagues back up his call, as all 3 other recent Ocugen reviews say Buy. Eastern Time on January 13, 2021 GlobeNewswire Jan-08-21 03:17PM Index-P/E-EPS (ttm)-0. The Average True Range (ATR) for Ocugen Inc. stock. Ocugen, Inc. S. OCUGEN INC OCGN STOCK CHART ANALYSIS | NEW PRICE TARGET BY ANALYSIS RATINGS OF $8 ! By Dady CJ On Feb 11, 2021. On Dec. 7300: 29. 47. At the end of the latest market close, Ocugen Inc. 95. 00. 9600: 6. 8M: Net profit margin Ocugen NASDAQ Updated Apr 5, 2021 9:01 AM. However, it’s important to keep in mind that the vast majority of analyst coverage on the stock is outdated. 50 price target after the company entered into a definitive agreement with Bharat Biotech to co-develop, supply, and Ocugen, Inc. With analysts defining $10-$15 as the low and high price targets, we arrive at a consensus price target of $12. 52% Join this channel to get access to perks:https://www. to Participate in a Cantor Fitzgerald Fireside Chat to Discuss COVAXIN COVID-19 Vaccine Development. Ocugen (NASDAQ:OCGN) Price Target Increased to $10. The implication for investors? Upside of 60% for the coming year. 31: $2. 00 to $8. comOCGN Stock Price: $10 Target (Up From $9) By Roth Capital - Pulse 2. com/channel/UCQvSqObd4nnhUWRm7fkRiRA/join----- The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. Ocugen stock forecast, ocgn share price prediction charts. The current price of Ocugen is the price at which Ocugen Inc is currently trading. 78% higher on its value in year-to-date trading and has touched a low of $0. The following Ocugen technical analysis is based on short term price movement and trend analysis. 82. 140,000 patient by 2030 — I can see why Ramakanth’s price target is so Cantor Fitzgerald analyst Kristen Kluska raised the price target on Ocugen, Inc. Ocugen stock forecast for 2021 and beyond: to invest, or not to invest? The average 12-month price target from four analysts that have issued an Ocugen share price forecast is $4. Q1 2020 Q2 2020 Q3 2020 Q4 2020; Estimate-0 The consensus price target as assigned by Wall Street analysts is $12. 9% and a 57. markets. *The average price target includes all analyst analysis, not just March 22, 2021 Ocugen Inc. (NASDAQ: OCGN), a In-depth view of key statistics and finances for OCUGEN, INC. e. OCGN stock surged 64% in after-hours trading on February 5, 2021, after an analyst said to buy the stock. C. 7200: 7. share. The average volatility ofmedia hypeimpact on the company stock price is over 100%. (NASDAQ:OCGN)’s share price rose 61. 19. 70, moving -1. ET on Motley Fool Keep Your Eyes on Ocugen Stock as It May Move Back to $20 Soon Mar. is Moderate Buy (2), with a target price of $12. 25. Shake Shack (NYSE:SHAK) had its price target increased by equities research analysts at Piper Sandler from $122. , a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. 77 in the current 52-week trading range. It is currently valued at $8. The stock had previously closed at $3. In that particular session, Stock kicked-off at the price of $2. 50. As a matter of fact, OCGN stock had traded below the $1 level for Date Type Description; 08/13/2021: Earnings: Q2 2021 Earnings Results: 08/13/2021: Misc: Q2 2021 Earnings Call: 03/18/2021: Earnings: Q4 2020 Earnings Results: 03/18/2021 08:30 EDT ocgn massive news || 81% effective + analysts raise price target! || analyst are bullish on usa eua In today’s video I talk about Ocugen & Bharat Biotech, Covaxin Vaccine. 0 Strong Sell). 06M-1. OCGN) soared 61. 03/04/2021 Ocugen, Inc. (NASDAQ: OCGN) had its price target raised by analysts at Roth Capital from $9. 70 by Chardan Capital. com Roth boosts Ocugen target after partnered vaccine shows `broad` efficacy The TOP Ships Inc. The eye disease specialist has shifted its focus to getting another Covid-19 vaccine to market. Mar. Pivot points are used to identify intraday support, resistance and target levels. 80, predicting that the stock has a possible downside of 27. The price decrease on the next newsis expected to be -38. Cantor OCGN Stock Price: $13 Target (Up From $0. The volatility of related hype on Ocugen is about 5522. 13. 386 comments. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. >Historical Ratings The table shows the mean historical analyst recommendation for the current period, along with the previous 1, 2, and 3 periods. The company traded as high as $5. - OCGN Stock Chart Technical Analysis for 03-04-2021 - Published on 03/04/2021 by ClayTrader On Dec. The shares were offered in a registered direct offering at $7. Wainwright, on the other hand, stated in their research note that they expect to see OCGN reach a price target of $4. Higher Rate Charters Boost 2021 EBITDA and Price Target, 03/18/2021. 3 Wall Street analysts that have issued a 1 year TXMD price target, the average TXMD price target is $7. 34B: Forward P/E: 2. Ocgn Stock Covid / Ocgn Stock Forecast Covid 19 Vaccine Enables 1007 Surge To Continue In 2021 : (ocgn) stock price, news, historical charts, analyst ratings and financial information from wsj. Join me while I discuss what happened and what I believe will happ According to analyst projections, OCGN’s forecast low is $10 with $15 as the target high. Today I break down a popular penny stock currently (OCGN). 1 Live Stock price in graph for Ocugen Inc (OCGN) 2. 90. According to data provided by FINVIZ, the current analyst consensus rating supposed at 2. (NASDAQ:OCGN)’s stock price shot up 18. (OCGN) is up over 4% at $0. On Monday, Roth Capital analyst initiated coverage of OCGN with a Buy rating and $1 price target. 50 a share. . Roth Capital Increases Ocugen (NASDAQ:OCGN) Price Target to $10. 7200: 6. While the situation remains very fluid, the 05:13 PM EST, 03/03/2021 (MT Newswires) -- US stocks dropped Wednesday as bond yields climbed again while the tech sector retreated. (OCGN) stock quote, history, news and other vital information to help you with your stock trading and investing. (OCGN) stock price forecast. Address 5 Great Valley Parkway, OCGN Chat Talk and Price Projections Please Like Share Comment and Subscribe I am not a stock adviser or broker. 92% on the last day (Friday, 5th Mar 2021) from $2. 50: 0. 33% Stock market timing forecast. Ocugen Reaches Analyst Target Price ETF Channel Staff - Thursday, December 24, 8:32 AM In recent trading, shares of Ocugen Inc (OCGN) have crossed above the average analyst 12-month target price of $0. 0 Strong Sell). Best entry is at the bottom of the triangle between 7. 74, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 39897. For investors, it is Ocugen price target raised to $8 from $1 at Roth Capital. This mean target price is expected by analysts. 02: Insider Own: 3. Stock’s current price level is 38. 50-3. 3% success rate. Ocugen Inc's stock rating is based on fundamental analysis. 00 to $135. 9000: 6. , March 29, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. Prior TTM) +99. 9, 2021 (Via Swaggy Stocks) Tue. 4 Wall Street analysts have issued ratings and price targets for Ocugen in the last 12 months. 1 Stock data per Thursday 1 Apr, 2021. 00 in a research note released on Wednesday, The Fly OCGN Stock Price: $10 Target (Up From $9) By Roth Capital By Amit Chowdhry March 7, 2021 The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target increase from $9 to $10 by Roth Capital. As a result, the price targets on the stock don’t take recent news into account. 79 . Ocgn | complete ocugen inc. 0 - pulse2. To be announced . 50. 7900: 7. Price Target Impact on Share Price Details; 3/4/2021: Roth Capital: Boost Price Target: Buy: $9. 29, while the Average True Range indicator is currently displaying 1. EPS. OcugenInc target prediction for May 2021 are 18. 72% for this period. The company also announced their 12 month price target at $4. This change lagged the S&P 500's daily gain of 1. February 2 Ocugen price target raised to $10 from $9 at Roth Capital 03/04/21-10:43AM EST Thefly. 63. OCGN is trading in the range of $6. 2 Quick links; 2. Ocugen Inc. Ocugen (OCGN – Research Report) received a Hold rating and a $13. The price has fallen in 6 of the last 10 days and is down by -24. m. 70, moving -1. (NASDAQ:OCGN)’s beta value is currently sitting at 4. 00 with a high estimate of $ 0. 70 with a price target of 2. In addition, Roth Capital maintains a buy rating on the stock. C. 21, 2020, Ocugen (NASDAQ: OCGN ) stock was trading at $0. Ocugen (NASDAQ:OCGN) Price Target Increased to $10. DCF Supports $13 OCGN Stock Forecast For 2021. 25 on the time of the announcement. 2021, yet the OCGN updated 2021 plan from 100M vaccines to 200M. The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target increase from $9 to $10 by Roth Capital. Share price at time of publishing: $2. 11. 50: Number Of Ratings: 4: FY Report Date: 12/2021: Last Quarter's Earnings OCGN will report Q1 2021 earnings on 05/07/2021. 38 and lowest value recorded on the day was $2. Chardan Capital Markets raised the price target for the Ocugen Inc. 00 and the lowest TXMD stock price forecast at $1. On Dec. (OCGN) on MSN Money. stock. 00% File Date Source Investor Avg Share Price Shares Shares Changed (%) Value ($1000) Value Changed (%) Cost Basis (x1000) Profit (x1000) Return (%) 2021-01-20: NP: FSMAX - Fidelity Extended Market Index Fund [click for advisory] This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when Ocugen (OCGN) stock price, charts, trades & the US's most popular discussion forums. 7000: 6. Wainwright reiterated a Hold rating on Ocugen (OCGN – Research Report). 51, the closing price of the Company’s common stock on the grant date. Wainwright Stick to Their Buy Rating for Ocugen Inc By Investing. 47% over the past month, closing at $2. 0 Sell, 5. May 7, 2021. Report Save. (NASDAQ: OCGN) increased by over 15% pre-market. Approximately 321,908,125 shares changed hands during mid-day trading, an increase of 390% from the average daily volume of 65,725,250 shares. 00 in a report published on Wednesday, The Fly reports. Announces the Cancellation of Stockholder Meeting Previously Adjourned to 11:00 a. (OCGN) called " Why Ocugen Is Set To Soar Again Tomorrow ". 76, 3. 00 to $10. 12, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 28399. 2021 nakedshortreport. 70. And Roth Capital analyst Zegbeh Jallah had assigned Ocugen a “Buy” rating. NASDAQ:OCGN OCUGEN INC. ocgn price target 2021